All In Biotech

Drug Trial Radar · NCT07003074

A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer

A Randomized, Open, Multicenter, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) Positive Recurrent or Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Jun 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 642 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

642

Planned (sponsor's estimate)

Start

Jun 23, 2025

Primary completion

Jul 2029

Study completion Jul 2030

Sponsor

Sponsor type
Industry
First posted
Jun 4, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase III trial adopts a randomized, open label, positive drug control, and multicenter trial design. Subjects who meet the criteria are randomly divided into 1:1 groups and receive treatment with TQB2102 injection or docetaxel combined with trastuzumab and pertuzumab, respectively.

Conditions

  • Breast Cancer

Interventions

  • TQB2102 for InjectionDrug

    TQB2102 is a next-generation HER2 Antibody-Drug Conjugate drug proposed for patients with HER2 positive Recurrent/Metastatic Breast Cancer.

  • Docetaxel combined + Trastuzumab +PertuzumabDrug

    Positive control.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response RateTime frame: Up to approximately 30 months
  2. Progression-Free SurvivalTime frame: Up to approximately 30 months

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Provincial Cancer Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Beijing Tiantan Hospital,Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, Gansu, China · Not yet recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, Gansu, China · Not yet recruiting

  • Shantou Central Hospital

    Shantou, Guangdong, China · Not yet recruiting

  • Affiliated Cancer Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Not yet recruiting

  • Huaihe Hospital of Henan University

    Kaifeng, Henan, China · Not yet recruiting

  • Puyang Oilfield General Hospital

    Puyang, Henan, China · Not yet recruiting

  • The Third People's Hospital of Zhengzhou

    Zhengzhou, Henan, China · Not yet recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Not yet recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • Jiangsu Provincial People's Hospital

    Nanjing, Jiangsu, China · Not yet recruiting

  • The first hospital of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Affiliated Zhongshan Hospital Of Dalian University

    Dalian, Liaoning, China · Not yet recruiting

  • Affiliated Zhongshan Hospital Of Dalian University

    Dalian, Liaoning, China · Not yet recruiting

  • Liaoning Provincial Cancer Hospital

    Shenyang, Liaoning, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'An Jiaoting Yniversity

    Xi'an, Shaanxi, China · Not yet recruiting

  • Cancer Hospital of Shandong First Medical University

    Jinan, Shandong, China · Not yet recruiting

  • Fudan University shanghai cancer center

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Shanxi Cancer Hospital

    Taiyuan, Shanxi, China · Not yet recruiting

  • Yuncheng Central Hospital, Shanxi Province

    Yuncheng, Shanxi, China · Not yet recruiting

  • Tianjin Cancer Hospital Airport Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • The Affiliated Tumor Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.